Document is current
Any future updates will be listed below
-
Authors
Morrison, Amy E. https://orcid.org/0000-0003-3353-1863
Papamargaritis, Dimitris
Jayasena, Channa N. https://orcid.org/0000-0002-2578-8223
Potdar, Neelam
Yates, Thomas
Biddle, Gregory J. H.
Hamza, Malak https://orcid.org/0009-0005-8483-8197
Davies, Melanie J. https://orcid.org/0000-0002-9987-9371
Reddy, Narendra L.
- License Information
-
More Information
Article History
First Online: 14 July 2025
Competing interests
: D.P. has received honoraria for lectures from Novo Nordisk, Eli Lilly, Boehringer Ingelheim and Johnson and Johnson and has received research grants from Novo Nordisk, Novo Nordisk UK Research Foundation and Academy of Medical Sciences/Diabetes UK. C.N.J. received research-led grants from Logixx Pharma. T.Y. is supported by the NIHR Leicester BRC and has received funding from Astra Zeneca for an investigator-initiated project. M.J.D. has acted as a consultant/advisor and speaker for Eli Lilly, Novo Nordisk and Sanofi, has attended advisory boards for Amgen, AstraZeneca, Biomea Fusion, Carmot/Roche, Sanofi, Zealand Pharma and Regeneron and has acted as a speaker for AstraZeneca and Boehringer Ingelheim. M.J.D. has received grants from AstraZeneca, Boehringer Ingelheim and Novo Nordisk. The other authors declare no competing interests.
